Changes of the cortex proteome and Apolipoprotein E in transgenic mouse models of Alzheimer's Disease

J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Aug 7;840(1):1-9. doi: 10.1016/j.jchromb.2006.05.019. Epub 2006 Jun 16.

Abstract

Transgenic mice carrying human Amyloid Precursor Protein mutations present amyloid plaque deposition in the brain upon aging. In this study, we characterized the changes of cortex proteome and endogenous Apolipoprotein E in these mice. Differential analysis of two-dimensional electrophoresis images revealed spots altered upon aging, transgene addition and plaque deposition. Alpha-synuclein and cytochrome oxidase polypeptide Va were up-regulated in transgenic mice. Upon aging, expression of ATP synthase alpha, alpha enolase, UMP-CMP kinase, and dihydropyrimidinase like-2 protein was modified. These proteins and their modification probably play a role in the amyloid aggregate formation in these mice.

Publication types

  • Congress
  • Overall

MeSH terms

  • Alzheimer Disease / metabolism*
  • Amino Acid Sequence
  • Animals
  • Apolipoproteins E / chemistry
  • Apolipoproteins E / genetics
  • Apolipoproteins E / metabolism*
  • Disease Models, Animal*
  • Electrophoresis, Gel, Two-Dimensional
  • Mass Spectrometry
  • Mice
  • Mice, Transgenic
  • Molecular Sequence Data
  • Proteome*

Substances

  • Apolipoproteins E
  • Proteome